L34- Multi-system Infections IV Flashcards
desribe the following features of Coxsackievirus A, B:
- family
- genome
- structure and size –> relationship with surviving environment
Picornaviridae family: (+)ssRNA
- naked (non-enveloped), icosahedral capsid
- relatively small (25-30nm)
-Since Naked: survives wide range pH (3-9), detergents, mild sewage treatment, heat
Coxsackievirus A, B:
- (1) reservoirs
- (2) common areas / locations it is usually found / spread
- (3) common season of transmission
- (4) are the most susceptible to severe infection
- (5) unique feature of viral shedding
1- humans 2- lower SES areas, schools / daycares 3- summer 4- neonates 5- intestinal viral shedding for 30 days (or longer), possibly asymptomatic
Coxsackievirus A, B:
- (1) route of transmission
- viral replication initially starts in (2) and continues in (3) –> leading to (4)
- viruses then infect (5) leading to (6)
1- fecal-oral transmission
2- mucosa and lymphoid tissue of tonsils and pharynx
3- M cells and lymphocytes in Peyer’s patches + enterocytes in intestinal mucosa
4- 1st viremia (+ shedding)
5- RES cells (LNs, spleen, liver)
6- 2nd viremia
Coxsackievirus A, B:
- after the 2nd viremia, viruses bind to (1) receptors, causing a (2) type infection in those cells
- replication occurs in the (cytosol/nucleus) and (4) is synthesized to form viral proteins in a (5) timeframe
1- ICAM-1, CD-55
2- lytic infections
3- cytosol
4- polyprotein
5- 10-15 mins after infecting cells
describe the major protective response to Coxsackievirus A, B and the role of each type
Antibodies:
-Secretory Abs: prevents initial infection in oropharynx and GIT
-Serum Abs: prevents viremic spread to target tissues –> and thus the disease
list the factors that affect the clinical syndromes caused by Coxsackievirus A, B
- viral serotype, tissue tropism
- portal of entry, infecting dose
- age, gender, immune/disease status
- pregnancy
Coxsackievirus A, B:
- (1) incubation period
- (2) are the possible syndromes from A type
- (3) are the possible syndromes from B type
1- 1-35 days
2- herpangina, hand-foot-and-mouth disease
3- pleurodynia, myocardial and pericardial infections
Herpangina:
- (1) pathogen
- (2) is the classic / hallmark finding
- (3) are the other associated symptoms
- (4) treatment
1- coxsackievirus A
2- vesicular ulcerated lesions around soft palate, uvula (uncommonly hard palate)
3- fever, sore throat, dysphagia –> anorexia, vomiting
4- self-limiting, Sx management
Hand-Foot-and-Mouth disease:
- (1) pathogen
- (2) is main finding, (3) is mild but usually present
- (4) progression
1- coxsackievirus A16
2- vesicular exanthema on hands, feet, mouth
3- mild fever
4- self-limiting, subsides in few days
coxsackievirus A16 is the main cause of…..
hand-foot-and-mouth disease
Pleurodynia, aka (1):
- (2) pathogen
- (3) initial symptoms
- (4) other symptoms
- (5) progression
1- Bornholm disease, ‘devil’s grip’
2- coxsackievirus B
3- sudden onset fever, unilateral lower thoracic pleuritic chest pain (excruciating)
4- abdominal pain, vomiting, malaise, muscle tenderness
5- last 4 days —> may relapse after asymptomatic period
In addition to pleurodynia, coxsackievirus B virus is also known to cause (1), mostly affecting (2) people- age. (3) symptoms will most always present, and (4) symptoms may also appear. (5) is the main progression that treatment tries to prevent.
1- myocardial and pericardial infections
2- elderly, young children, neonate (life threatening)
3- febrile illness, sudden unexplained heart failure
4- cyanosis, tachycardia, cardiomegaly, hepatomegaly
5- infection associated mortality (high in these patients)
Coxsackievirus A, B diagnosis:
- mainly by (1) method
- (2) are alternatives
-(3) is results from CSF sample (aseptic meningitis), compared to (4) results from bacterial meningitis
1- serology
2- culture (not always possible), ELISA, RT-PCR
3- elevated glucose, elevated proteins
4- low glucose, elevated proteins
HHV-4 = (1):
- (2) family
- (3) genome and structure
EBV- epstein-barr virus
- gamma-herpesviridae subfamily
- linear dsDNA, enveloped
EBV:
- (1) is most common route of transmission
- (2) is the most common clinical manifestation
- (3) may occur after (2)
- (4) are the dangerous complications that develop from previous EBV infection
- (5) incubation time
1- saliva (blood, semen, transfusions, transplants are others)
2- infectious mononucleosis (Mono)
3- latent infection — can be reactivated later in life
4- B cell lymphomas, hairy oral leukoplakia
5- up to 2 mos